Welcome to YLOAN.COM
yloan.com » Marketing » Aarkstore Enterprise---neurodegenerative Market Forecast To 2013
Marketing Advertising Branding Careers-Employment Change-Management Customer Service Entrepreneurialism Ethics Marketing-Direct Negotiation Outsourcing PR Presentation Resumes-Cover-Letters Sales Sales-Management Sales-Teleselling Sales-Training Strategic-Planning Team-Building Top7-or-Top10-Tips Workplace-Communication aarkstore corporate advantages development collection global purchasing rapidshare grinding wildfire shipping trading economy wholesale agency florida attorney strategy county consumer bills niche elliptical

Aarkstore Enterprise---neurodegenerative Market Forecast To 2013

The neurodegenerative space is a top-selling pharmaceutical market

. Consider these facts:

Sales among all drugs profiled in this report total $18.5 billion and are expected to increase 62% to $29.7 billion by 2012.

The majority of this growth is projected to be in multiple sclerosis, which will increase from a $12.6 billion market to upwards of $20 billion in 2012.

Neurodegenerative disease patients have few treatment options, which often provide only limited effectiveness. Companies that can invest in and develop new, tolerable therapies which improve patients" quality of life could see hundreds of millions "" or even billions "" of dollars in sales.


In one convenient, easy-to-access format, Neurodegenerative Market Forecast to 2013 provides a compelling, full picture of the Alzheimer"s, Multiple Sclerosis and Parkinson"s markets.

Detailed Product Profiles

CEI"s veteran analysts examine 40 brands representing different classes and stages of development. The profiled products represent over 90% of sales in the neurodegenerative market. Each drug profile has the following components:

Drug history

Competitive and strategic positioning:

Current status of drug

Sales position within its class

Presence or strength of competition

Market growth opportunities:

Analysis combines new/current sales or clinical trial info with projections, predictions, insights

Analysis supported by sales projection charts, covering up to the next 7 years

Materiality charts, for 2007 and 2012

Charts containing market exclusivity and patent information for approved drugs

Clinical trial data tables to quickly show clinical detail:

Describes trial and why drug is in its current stage

Progress of drug

Analyses weigh the challenges and opportunities of each indication, class, and individual brand. Which brands will reap dividends and why? Whose sales are expected to drop? Which experimental therapies represent the next great medical breakthrough? Who will be the markets" leaders in the next decade?

For more information please contact :

http://www.aarkstore.com/reports/Neurodegenerative-Market-Forecast-to-2013-8077.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore Enterprise
Article Marketing—Do You Know What You Are Missing Aarkstore Enterprise---thought Leader Fair-market Value: Compensation Benchmarks And Procedures >flipping Property Is The Way To More Profits Appliance Giant Defection Profits Too Thin Channels To Seek Channels For Voice Self Aarkstore Enterprise---diabetes Market Forecast To 2013 Aarkstore Enterprise---oncology Market Forecast To 2013 Zenith Grinding Mill Process Fly Ash Wide Market Prospect Ways to Make Investment in the Stock Markets How To Have A Successful Affiliate Marketing Program Aarkstore Enterprise---pharmaceutical Product Relaunch: Preserving Market Share Through Line Extensi Aarkstore Enterprise---early-stage Pharmaceutical Marketing Budgets: Preparing For Product Launch Aarkstore Enterprise---post-launch Brand Marketing In Select Affiliate Markets How to Launch an Email Marketing Campaign
print
www.yloan.com guest:  register | login | search IP(216.73.216.60) California / Anaheim Processed in 0.017175 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 56 , 2546, 66,
Aarkstore Enterprise---neurodegenerative Market Forecast To 2013 Anaheim